Concepedia

Deborah Lehrer

DL

14

Publications

908

Citations

11

H-Index

1963

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Cornell University

NewYork–Presbyterian Hospital

National Cancer Institute

New York Hospital Queens

Deborah Lehrer is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, pharmacotherapy, and oncology.

Top concepts

Publications per year

1963–2018

14

Publications

14

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

Abby B. Siegel, E. Cohen, Allyson J. Ocean et al. · Journal of Clinical Oncology · 2008 · 506 citations · Full text

Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial

Chrisann Kyi, Vladimir Roudko, Rachel Lubong Sabado et al. · Clinical Cancer Research · 2018 · 127 citations · Full text

Bevacizumab in unresectable hepatocellular carcinoma (HCC) for patients without metastasis and without invasion of the portal vein

Jonathan D. Schwartz, M. Schwartz, Deborah Lehrer et al. · Journal of Clinical Oncology · 2006 · 56 citations

, , +21

Thalidomide in Advanced Hepatocellular Carcinoma with Optional Low-Dose Interferon-α2a upon Progression

Jonathan D. Schwartz, Max W. Sung, Myron Schwartz et al. · The Oncologist · 2005 · 35 citations · Full text

Bevacizumab in hepatocellular carcinoma (HCC) in patients without metastasis and without invasion of the portal vein

Jonathan D. Schwartz, M. Schwartz, Deborah Lehrer et al. · Journal of Clinical Oncology · 2005 · 27 citations

, , +18

Rows per page

1–5 of 14